表紙
市場調查報告書

全球人工淚液市場

Artificial Tears

出版商 Global Industry Analysts, Inc. 商品編碼 248932
出版日期 內容資訊 英文 143 Pages
商品交期: 最快1-2個工作天內
價格
Back to Top
全球人工淚液市場 Artificial Tears
出版日期: 2019年05月01日內容資訊: 英文 143 Pages
簡介

本報告提供全球人工淚液市場相關調查,彙整市場現狀與今後的成長預測,各地區趨勢,及加入此市場的主要企業的簡介等資料。

第1章 簡介,調查方法,產品定義

第2章 產業概要

  • 乾眼症
  • 人工淚液
  • 其他乾眼症治療
  • 現在及未來分析
  • 發展中國家預測將強力成長
  • 乾眼症症候群的罹患率與發病率
  • 乾眼症的多元化性質藥物製造商課題
  • 高齡化
  • 市場課題
  • 缺乏明確的產品差異化
  • 低的患者適合性限制市場機會

第3章 值得一提的市場趨勢

第4章 乾眼症症候群;概要

  • 一般的眼科症狀
  • 原因
  • 診斷
  • 乾眼的多因素性質對製藥商構成挑戰
  • 乾眼症症候群的診斷和治療 其他

第5章 產品概要

  • 概要
  • 人工淚液的種類
  • 使用和容量
  • 人工淚液的發展
  • 第一代
  • 第二代
  • 第三代
  • 第四代
  • 替代治療方法

第6章 競爭環境

  • 主要企業
  • 單回使用
  • 複數使用
  • 產品上市/認證/引進
  • 近幾年的產業活動

第7章 全球市場預測

第8章 各地區市場趨勢

  • 美國
  • 加拿大
  • 日本
  • 歐洲
  • 亞太地區
  • 南美
  • 其他各國

第9章 企業簡介

本網頁內容可能與最新版本有所差異。詳細情況請與我們聯繫。

目錄
Product Code: MCP-7743

This report analyzes the worldwide markets for Artificial Tears in US$ Thousand. The report provides separate comprehensive analytics for the US, Canada, Japan, Europe, Asia-Pacific, Latin America, and Rest of World. Annual estimates and forecasts are provided for the period 2016 through 2024. Also, a five-year historic analysis is provided for these markets. Market data and analytics are derived from primary and secondary research. Company profiles are primarily based on public domain information including company URLs. The report profiles 49 companies including many key and niche players such as -

Allergan, Inc.
Akorn, Inc.
Bausch & Lomb Incorporated
Johnson & Johnson
Novartis International AG
Santen Pharmaceuticals Co, Ltd.

Table of Contents

1. INTRODUCTION, METHODOLOGY & PRODUCT DEFINITIONS

  • Study Reliability and Reporting Limitations
  • Disclaimers
  • Data Interpretation & Reporting Level
  • Quantitative Techniques & Analytics
  • Product Definitions and Scope of Study

2. INDUSTRY OVERVIEW

  • Dry Eyes - A Lucrative Segment of Ophthalmology Market
    • Table 1: Global Ophthalmology Market (2017): Percentage Share Breakdown by Product Segment (includes corresponding Graph/Chart)
  • Artificial Tears: The First Line and Mainstay Treatment for Dry Eyes
    • Table 2: Global Dry Eye Treatment Market (2017): Percentage Share Breakdown of Revenues by Over-the-Counter and Rx Segments (includes corresponding Graph/Chart)
  • Other Therapies for Dry Eye
  • Current & Future Analysis
  • Developing Countries Display Strong Growth Prospects
  • Under-reporting of DES Condition Stifles Market Opportunities
  • Prevalence and Incidence of Dry Eye Syndrome
    • Table 3: Prevalence of Dry Eye Syndrome Across Select Countries (in %) (includes corresponding Graph/Chart)
  • Select Stats on Prevalence Rates
  • Concentrated Prescription Dry Eye Products Market Benefits OTC Market
  • Multi-Factorial Nature of Dry Eye Poses Challenges to Drug Makers
  • Aging Population - A Major Growth Driver
    • Table 4: Global Population Demographics (2017 & 2020P): Percentage Breakdown of Population by Age Group - Below 40 Years and 40 Years & Above (includes corresponding Graph/Chart)
  • Market Challenges
  • Lack of Clear Product Differentiation
  • Drug Formulation Fraught with Difficulties
  • Low Patient Compliance Limits Market Opportunities

3. NOTEWORTHY MARKET TRENDS

  • Companies Focus on New Formulations to Improve Results
  • Preference for Preservative-Free Artificial Tears on Rise
  • Management of Dry Eyes Post Eye Surgery Drives Demand for Artificial Tears
    • Table 5: Number of LASIK Surgeries in US and Europe (2015-2020) (in '000) (includes corresponding Graph/Chart)
  • Rise in Mobile Workforce and Number of Smartphone Addicts Spurs Growth Prospects
    • Table 6: Global Smartphone Adoption Rate (2013-2020) (includes corresponding Graph/Chart)
    • Table 7: Number of Mobile Phone Users Worldwide (2014-2020) (in Billions) (includes corresponding Graph/Chart)
  • An Upswing in Contact Lens Wearers Unfolds New Opportunities
    • Table 8: Penetration of Contact Lenses in Select Countries/Regions (2017) (includes corresponding Graph/Chart)
  • Manufacturers Focus Efforts on Formulating the Right Artificial Tears for Contact Lens Wearers
  • Environmental Factors Play an Important Role
  • Nanotechnology and Other Innovative Delivery Techniques Gain Attention in DES Treatment
  • Direct-to-Customer Promotions: A Primary Marketing Strategy

4. DRY EYE SYNDROME - AN OVERVIEW

  • Dry Eye - A Common Ophthalmic Condition
  • Causes of Dry Eyes
  • Diagnosis of Dry Eye Syndrome
  • Multi-Factorial Nature of Dry Eye Poses Challenge to Drug Makers
  • Bridging Chasm between Diagnosis and Treatment of Dry Eye Syndrome
  • Product Options for Dry Eye Syndrome: Breakdown by Palliative Therapies and Targeted Therapies
  • KCS Inflammation Cycle
  • Common Symptoms of KCS
  • Risk Factors for Dry Eye Disease
  • Impact of Dry Eye Syndrome on Routine Daily Life Activities: Ranking based on Intensity of Impact Felt by Patients
  • Novel Approaches to Revolutionize Dry Eye Therapy
  • Anti-Inflammatory Drugs
  • Mucin Secretagogues
  • Hormonal Therapies
  • Omega-3 Drugs
  • Muco-Mimetics
  • Barrier-function Drugs

5. PRODUCT OVERVIEW

  • Artificial Tears - An Overview
  • Types of Artificial Tears
  • Artificial Tears Usage and Dosage
  • Evolution of Artificial Tears
  • First-Generation
  • Second-Generation
  • Third-Generation
  • Fourth-Generation
  • Alternate Treatment Methods

6. COMPETITIVE LANDSCAPE

  • Leading Players
    • Table 9: Leading Players in the Global Artificial Tears Market (2016): Percentage Share Breakdown of Sales by Company (includes corresponding Graph/Chart)
  • Artificial Tears for Dry Eye Syndrome-Single-use (Unit dose)
  • Artificial Tears for Dry Eye Syndrome-Multi dose
  • 6.1 Focus on Select Global Players
  • Allergan plc (Ireland)
  • Akorn, Inc. (USA)
  • Bausch & Lomb Incorporated (USA)
  • Johnson & Johnson (USA)
  • Novartis International AG (Switzerland)
  • Alcon, Inc. (Switzerland)
  • Santen Pharmaceuticals Co, Ltd. (Japan)
  • 6.2 Product Launches/Approvals/Introductions
  • Alcon Launches Systane Complete
  • Grafton Optical Adds I-LID 'N LASH(r) Ocular Hygiene Product Line from I-MED Pharma
  • Allergan Introduces TrueTear (Allergan)
  • Novaliq Introduces NovaTears(r)
  • Allergan Launches REFRESH OPTIVE(r) MEGA-3
  • Thea Pharmaceuticals Introduces Thealoz Duo
  • 6.3 Recent Industry Activity
  • Novartis to Spinoff Alcon
  • I-MED Pharma Signs Distribution Agreement with IMEX
  • Novartis to In-license ECF843 for Ophthalmic Indications
  • Johnson & Johnson Acquires Abbott Medical Optics

7. GLOBAL MARKET PERSPECTIVE

    • Table 10: World Recent Past, Current & Future Analysis for Artificial Tears by Geographic Region/ Country - US, Canada, Japan, Europe, Asia-Pacific (excluding Japan), Latin America, and Rest of World Markets Independently Analyzed with Annual Sales Figures in US$ Thousand for Years 2016 Through 2024 (includes corresponding Graph/Chart)
    • Table 11: World Historic Review for Artificial Tears by Geographic Region/Country - US, Canada, Japan, Europe, Asia-Pacific (excluding Japan), Latin America, and Rest of World Markets Independently Analyzed with Annual Sales Figures in US$ Thousand for Years 2011 Through 2015 (includes corresponding Graph/Chart)
    • Table 12: World 14-Year Perspective for Artificial Tears by Geographic Region/Country - Percentage Breakdown of Dollar Sales for US, Canada, Japan, Europe, Asia-Pacific (excluding Japan), Latin America, and Rest of World Markets for Years 2011, 2018 & 2024 (includes corresponding Graph/Chart)

8. REGIONAL MARKET PERSPECTIVE

  • 8.1 The United States
  • A. Market Analysis
    • Current and Future Analysis
    • Table 13: Prevalence of Dry Eye Disease in the US (2017): Percentage Breakdown by Dry Eye Category (includes corresponding Graph/Chart)
    • Demographics Remain an Important Growth Driver
    • Table 14: US Population Demographics (2015-2030): Percentage Breakdown of Population by Age Group (includes corresponding Graph/Chart)
    • Table 15: Prevalence of Dry Eye Condition in the US (2014) (includes corresponding Graph/Chart)
    • Table 16: US Women Population (2015-2030): Percentage Breakdown of Population by Age Group (includes corresponding Graph/Chart)
    • Lifestyle and Environmental Factors - A Major Reason Behind Rise in Eye Care Market
    • Air Pollution Bears Close Association with DES Risk
  • B. Market Analytics
    • Table 17: US Recent Past, Current & Future Analysis for Artificial Tears Market Analyzed with Annual Sales Figures in US$ Thousand for Years 2016 Through 2024 (includes corresponding Graph/Chart)
    • Table 18: US Historic Review for Artificial Tears Market Analyzed with Annual Sales Figures in US$ Thousand for Years 2011 Through 2015 (includes corresponding Graph/Chart)
  • 8.2 Canada
  • Market Analysis
    • Table 19: Canadian Recent Past, Current & Future Analysis for Artificial Tears Market Analyzed with Annual Sales Figures in US$ Thousand for Years 2016 Through 2024 (includes corresponding Graph/Chart)
    • Table 20: Canadian Historic Review for Artificial Tears Market Analyzed with Annual Sales Figures in US$ Thousand for Years 2011 Through 2015 (includes corresponding Graph/Chart)
  • 8.3 Japan
  • A. Market Analysis
    • Current and Future Analysis
  • B. Market Analytics
    • Table 21: Japanese Recent Past, Current & Future Analysis for Artificial Tears Market Analyzed with Annual Sales Figures in US$ Thousand for Years 2016 Through 2024 (includes corresponding Graph/Chart)
    • Table 22: Japanese Historic Review for Artificial Tears Market Analyzed with Annual Sales Figures in US$ Thousand for Years 2011 Through 2015 (includes corresponding Graph/Chart)
  • 8.4 Europe
  • A. Market Analysis
    • Current and Future Analysis
    • Market Overview
    • Overview of Select Markets
      • Germany
      • Italy
      • UK
      • Russia
  • B. Market Analytics
    • Table 23: European Recent Past, Current & Future Analysis for Artificial Tears by Geographic Region/Country - France, Germany, Italy, UK, Spain, Russia, and Rest of Europe Markets Independently Analyzed with Annual Sales Figures in US$ Thousand for Years 2016 Through 2024 (includes corresponding Graph/Chart)
    • Table 24: European Historic Review for Artificial Tears by Geographic Region/Country - France, Germany, Italy, UK, Spain, Russia, and Rest of Europe Markets Independently Analyzed with Annual Sales Figures in US$ Thousand for Years 2011 Through 2015 (includes corresponding Graph/Chart)
    • Table 25: European 14-Year Perspective for Artificial Tears by Geographic Region/Country - Percentage Breakdown of Dollar Sales for France, Germany, Italy, UK, Spain, Russia, and Rest of Europe Markets for Years 2011, 2018 & 2024 (includes corresponding Graph/Chart)
  • 8.5 Asia-Pacific
  • A. Market Analysis
    • Current and Future Analysis
    • Focus on Select Regional Markets
      • Australia
      • China
      • India
  • B. Market Analytics
    • Table 26: Asia-Pacific Recent Past, Current & Future Analysis for Artificial Tears by Geographic Region/Country - China, India, and Rest of Asia-Pacific Markets Independently Analyzed with Annual Sales Figures in US$ Thousand for Years 2016 Through 2024 (includes corresponding Graph/Chart)
    • Table 27: Asia-Pacific Historic Review for Artificial Tears by Geographic Region/Country - China, India, and Rest of Asia-Pacific Markets Independently Analyzed with Annual Sales Figures in US$ Thousand for Years 2011 Through 2015 (includes corresponding Graph/Chart)
    • Table 28: Asia-Pacific 14-Year Perspective for Artificial Tears by Geographic Region/Country - Percentage Breakdown of Dollar Sales for China, India, and Rest of Asia-Pacific Markets for Years 2011, 2018 & 2024 (includes corresponding Graph/Chart)
  • 8.6 Latin America
  • A. Market Analysis
    • Current and Future Analysis
  • B. Market Analytics
    • Table 29: Latin American Recent Past, Current & Future Analysis for Artificial Tears Market Analyzed with Annual Sales Figures in US$ Thousand for Years 2016 Through 2024 (includes corresponding Graph/Chart)
    • Table 30: Latin American Historic Review for Artificial Tears Market Analyzed with Annual Sales Figures in US$ Thousand for Years 2011 Through 2015 (includes corresponding Graph/Chart)
  • 8.7 Rest of World
  • Market Analysis
    • Table 31: Rest of World Recent Past, Current & Future Analysis for Artificial Tears Market Analyzed with Annual Sales Figures in US$ Thousand for Years 2016 Through 2024 (includes corresponding Graph/Chart)
    • Table 32: Rest of World Historic Review for Artificial Tears Market Analyzed with Annual Sales Figures in US$ Thousand for Years 2011 Through 2015 (includes corresponding Graph/Chart)

9. COMPANY PROFILES Total Companies Profiled: 49 (including Divisions/Subsidiaries - 54) The United States (19) Canada (3) Japan (3) Europe (14) - France (1) - Germany (3) - The United Kingdom (3) - Italy (1) - Spain (1) - Rest of Europe (9) Asia-Pacific (Excluding Japan) (12) Middle East (1) Africa (2) ARTIFICIAL TEARS MCP-7743 CONTENTS

Back to Top